These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31442464)

  • 21. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
    Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
    Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
    Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
    Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
    Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
    Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe rhabdomyolysis due to idiopathic inflammatory myopathies, a wary manifestation of a heterogenous pathology.
    Schepens N; Herroelen PH; Decavele AS; Vanacker A
    Acta Clin Belg; 2023 Apr; 78(2):160-164. PubMed ID: 35491881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
    Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
    Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses.
    Angeli F; Pedretti E; Garrafa E; Fredi M; Ceribelli A; Franceschini F; Cavazzana I
    Diagnostics (Basel); 2024 Sep; 14(19):. PubMed ID: 39410596
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
    Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
    Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].
    Kowalska-Oledzka E; Stern LZ
    Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies.
    Conticini E; d'Alessandro M; Cameli P; Bergantini L; Pordon E; Cassai L; Cantarini L; Bargagli E; Frediani B; Porcelli B
    Immunol Res; 2023 Oct; 71(5):735-742. PubMed ID: 37133680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and subtyping of idiopathic inflammatory myopathies: caution required in the use of myositis autoantibodies.
    Anderson HT; O'Donnell JL; Tustin P; Steele R
    Intern Med J; 2024 Apr; 54(4):682-686. PubMed ID: 38444396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot.
    Bories E; Fortenfant F; Pugnet G; Renaudineau Y; Bost C
    Semin Arthritis Rheum; 2022 Aug; 55():151998. PubMed ID: 35427882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre.
    Martel C; Vignaud G; Liozon E; Magy L; Gallouedec G; Ly K; Bezanahary H; Cypierre A; Lapébie FX; Palat S; Gondran G; Jauberteau MO; Fauchais AL
    Clin Exp Rheumatol; 2016; 34(5):918-924. PubMed ID: 27494325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review: Systematic review.
    Van Horebeek N; Vulsteke JB; Bossuyt X; Claeys KG; Dillaerts D; Poesen K; Lenaerts J; Van Damme P; Blockmans D; De Haes P; De Langhe E
    Semin Arthritis Rheum; 2021 Apr; 51(2):486-494. PubMed ID: 33831755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the Autoantibody Response to the OJ Antigenic Complex.
    Fritzler MJ; Bentow C; Satoh M; McHugh N; Ghirardello A; Mahler M
    Diagnostics (Basel); 2023 Jan; 13(1):. PubMed ID: 36611448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
    Zhao L; Su K; Liu T; Sun D; Jiang Z
    Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.